TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33198070

Group type: EXPERIMENTAL
Intervention: Knowledge and attitude towards retrograde peri-implantitis (RPI)
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: Recognition of radiographic representation of RPI
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: Treatment modality for RPI
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: Knowledge of management strategies for RPI
Number of subjects: 475
Study: 36438075

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH) plus low-dose aspirin treatment (Group A = 85)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Low-dose aspirin treatment only (Group B = 88)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Subgroup analysis for polycystic ovary syndrome (PCOS) patients
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH) plus low-dose aspirin treatment (Group A)
Number of subjects: 173
Study: 33307444

Group type: EXPERIMENTAL
Intervention: High social isolation
Number of subjects: 642

Group type: COMPARATOR
Intervention: Low social isolation
Number of subjects: 642

Group type: EXPERIMENTAL
Intervention: Social isolation
Number of subjects: 642
Study: 36357551

Group type: EXPERIMENTAL
Intervention: Video modeling technique (watched the video before the consultation)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (did not watch the video before the consultation)
Number of subjects: 20
Study: 34424549

Group type: EXPERIMENTAL
Intervention: Piroctone olamine (PO) containing shampoo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Piroctone olamine (PO) containing leave-on treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo formulations
Number of subjects: 0
Study: 32022904

Group type: EXPERIMENTAL
Intervention: Restrictive fluid therapy regimen
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard management
Number of subjects: 100
Study: 35504165

Group type: EXPERIMENTAL
Intervention: Krill oil supplementation (4g/day) for 6 months
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 102
Study: 33186729

Group type: EXPERIMENTAL
Intervention: Intranasal Fentanyl (INF)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 35697942

Group type: EXPERIMENTAL
Intervention: Treadmill training
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Physiotherapy
Number of subjects: 105
Study: 33562001

Group type: EXPERIMENTAL
Intervention: Supportive psychotherapy with an individually selected diet plan
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional slimming therapies using an individual diet plan and dietitian’s care
Number of subjects: 60
Study: 34357781

Group type: EXPERIMENTAL
Intervention: Exemestane 25 mg by mouth once daily and entinostat 5 mg by mouth once weekly (EE)
Number of subjects: 608

Group type: COMPARATOR
Intervention: Exemestane 25 mg by mouth once daily and placebo 5 mg by mouth once weekly (EP)
Number of subjects: 608
Study: 34990582

Group type: EXPERIMENTAL
Intervention: Angiography-derived physiology guided PCI
Number of subjects: 2540

Group type: COMPARATOR
Intervention: Usual care PCI
Number of subjects: 2540
Study: 34184336

Group type: EXPERIMENTAL
Intervention: Intravenous iron preoperatively
Number of subjects: 0

Group type: COMPARATOR
Intervention: No intravenous iron (control group)
Number of subjects: 0
Study: 32197956

Group type: EXPERIMENTAL
Intervention: Zopiclone 15 mg
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 36339068

Group type: EXPERIMENTAL
Intervention: esmolol
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ephedrine
Number of subjects: 30

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study: 32358640

Group type: EXPERIMENTAL
Intervention: Probiotic (AminoAlta™, a multi-strain probiotic with 5 billion CFU L. paracasei LP-DG® and 5 billion CFU L. paracasei LPC-S01)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 35938852

Group type: EXPERIMENTAL
Intervention: 12-month reduced-calorie weight-loss diet and exercise programme
Number of subjects: 192

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Weight-loss interventions (≥10% weight loss)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Weight-loss interventions (0-10% weight loss)
Number of subjects: 192
Study: 33092758

Group type: EXPERIMENTAL
Intervention: Radial strain-guided LV lead placement with multimodality imaging
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (standard CRT lead placement)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Radial strain-guided LV lead placement
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 102
Study: 34054079

Group type: EXPERIMENTAL
Intervention: Active laser PBM (λ = 808 nm, optical output = 100 mW, total energy = 42 J)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo laser PBM
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 22
Study: 33120085

Group type: EXPERIMENTAL
Intervention: DNA methylation analysis using Mendelian randomization approach
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: Gene expression data analysis
Number of subjects: 592
Study: 32703245

Group type: EXPERIMENTAL
Intervention: Culturally based palliative care tele-consult program (n=176)
Number of subjects: 352

Group type: COMPARATOR
Intervention: Usual hospital care (n=176)
Number of subjects: 352
Study: 35656795

Group type: EXPERIMENTAL
Intervention: CLDN18.2 positivity in PDAC patients
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: CLDN18.2 positivity in highly differentiated PDAC
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: CLDN18.2 positivity in intermediate differentiated PDAC
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: CLDN18.2 positivity in low differentiated PDAC
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Association of CLDN18.2 positivity with clinicopathological characteristics
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: CLDN18.2 positivity and survival prediction
Number of subjects: 302
Study: 34051666

Group type: EXPERIMENTAL
Intervention: External Focus of Modeling (EFM)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Internal Focus of Modeling (IFM)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Both groups (EFM and IFM)
Number of subjects: 24
Study: 36071317

Group type: EXPERIMENTAL
Intervention: Vignette depicting low support needs
Number of subjects: 499

Group type: EXPERIMENTAL
Intervention: Vignette depicting high support needs
Number of subjects: 499

Group type: COMPARATOR
Intervention: Participants' nationality (South Korean vs. American)
Number of subjects: 499
Study: 33512442

Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study: 35666289

Group type: EXPERIMENTAL
Intervention: Fesoterodine 4 mg (continuous usage)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Fesoterodine 4 mg (on-demand usage)
Number of subjects: 100
Study: 34242498

Group type: EXPERIMENTAL
Intervention: Normobaric oxygen (NBO) at 8 L/min
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (room air)
Number of subjects: 50
Study: 32255318

Group type: EXPERIMENTAL
Intervention: Removal of nephrotoxic agents
Number of subjects: 80
Study: 34523193

Group type: EXPERIMENTAL
Intervention: Mental imagery-based self-regulation intervention (physical activity)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Risk ladder condition (physical activity)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Goal planning
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Self-efficacy, image clarity, and affective attitudes
Number of subjects: 500
Study: 33040481

Group type: EXPERIMENTAL
Intervention: FHNSI-10
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: FHNSI-7
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: FHNSI-10, FHNSI-7, pain, fatigue, swallowing, and breathing symptom scores
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: FHNSI-10, FHNSI-7, pain, fatigue, and breathing symptom scores
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Symptom indexes and individual symptom scores
Number of subjects: 239
Study: 35668503

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with nicotine patch
Number of subjects: 96

Group type: COMPARATOR
Intervention: Acupuncture combined with sham nicotine patch
Number of subjects: 96

Group type: COMPARATOR
Intervention: Sham acupuncture combined with nicotine patch
Number of subjects: 96

Group type: COMPARATOR
Intervention: Sham acupuncture combined with sham nicotine patch
Number of subjects: 96
Study: 32724929

Group type: EXPERIMENTAL
Intervention: Classic Turkish music (Saba or Rast Tune)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Classical music (Vivaldi)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Slow rock music
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no music)
Number of subjects: 80
Study: 35357671

Group type: EXPERIMENTAL
Intervention: Lower-sodium oxybate (Xywav®)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33125623

Group type: EXPERIMENTAL
Intervention: Structured Function-Based Intervention for Elopement
Number of subjects: 24
Study: 32721482

Group type: EXPERIMENTAL
Intervention: Restoration with resin composite core (EBC)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Restoration with resin composite core and a fiber post (EBP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No restoration (EB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intact teeth (Control)
Number of subjects: 60
Study: 35538481

Group type: EXPERIMENTAL
Intervention: Multimodal active learning (flipped classroom and modified Peyton's 4-steps method)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Simulation alone (control group)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Multimodal active learning
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Both groups (IG and CG)
Number of subjects: 89
Study: 32007834

Group type: EXPERIMENTAL
Intervention: Home-based aerobic exercise intervention
Number of subjects: 217

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 217
Study: 32041190

Group type: EXPERIMENTAL
Intervention: CDSS (Clinical Decision Support System) prompting delivery of a brief alcohol intervention (educational alcohol resource)
Number of subjects: 5702

Group type: COMPARATOR
Intervention: No CDSS (Control)
Number of subjects: 5702
Study: 35789530

Group type: EXPERIMENTAL
Intervention: Lifestyle modification combined with TEAS four times weekly for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Lifestyle modification
Number of subjects: 60
Study: 33832145

Group type: EXPERIMENTAL
Intervention: Pulsed radiofrequency (PRF) stimulation of the suprascapular nerve
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Physical therapy
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both PRF stimulation and physical therapy
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 90
Study: 36056378

Group type: EXPERIMENTAL
Intervention: Cycling intervention in ICU
Number of subjects: 28

Group type: COMPARATOR
Intervention: Routine physiotherapy
Number of subjects: 28
Study: 33789009

Group type: EXPERIMENTAL
Intervention: Sotatercept 0.3 mg/kg every 3 weeks
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Sotatercept 0.7 mg/kg every 3 weeks
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Sotatercept
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study: 36263522

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 33326970

Group type: EXPERIMENTAL
Intervention: ART sealants
Number of subjects: 187

Group type: COMPARATOR
Intervention: Nonsealed molars
Number of subjects: 187
Study: 35936770

Group type: EXPERIMENTAL
Intervention: Successful Aging Group (SAG)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Physical Activity Group (PAG)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Successful Aging Group (SAG) females
Number of subjects: 56
Study: 32331041

Group type: EXPERIMENTAL
Intervention: Pimavanserin (PIM) 34 mg/day
Number of subjects: 207

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 207
Study: 36175968

Group type: EXPERIMENTAL
Intervention: Low-dose titrated morphine hydrochloride administered intravenously for 24 hours
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl) administered for 24 hours
Number of subjects: 22
Study: 33975133

Group type: EXPERIMENTAL
Intervention: Machine learning model predicting disposition based on triage assessment and historical information.
Number of subjects: 585142

Group type: EXPERIMENTAL
Intervention: Machine learning model performance analysis.
Number of subjects: 585142
Study: 32734722

Group type: EXPERIMENTAL
Intervention: Additional tunica vaginalis flap coverage
Number of subjects: 50

Group type: COMPARATOR
Intervention: Dartos-only coverage (Control)
Number of subjects: 50
Study: 35229658

Group type: EXPERIMENTAL
Intervention: Acupuncture intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (implied control)
Number of subjects: 0
Study: 32900246

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) at 40% of maximal inspiratory pressure (IPmax) for 20 min/session, thrice/week, over 12 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo IMT at 5% of IPmax
Number of subjects: 34
Study: 33371126

Group type: EXPERIMENTAL
Intervention: Pingmu Decoction combined with acupuncture
Number of subjects: 120

Group type: COMPARATOR
Intervention: Basic western medicine treatment
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Adverse reactions
Number of subjects: 120
Study: 36149241

Group type: EXPERIMENTAL
Intervention: Modern external ring fixation (n = 127)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Internal fixation (n = 133)
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Modern external ring fixation
Number of subjects: 254

Group type: COMPARATOR
Intervention: Internal fixation
Number of subjects: 254
Study: 34682375

Group type: EXPERIMENTAL
Intervention: Condition A (Self and Elaboration)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Condition B (Self and No Elaboration)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Condition C (Other and Elaboration)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Condition D (Other and No Elaboration)
Number of subjects: 84
Study: 32975076

Group type: EXPERIMENTAL
Intervention: miR‐382‐5p mimics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: pc‐PTEN
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: mimics+pc‐PTEN
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 34366201

Group type: EXPERIMENTAL
Intervention: Digital Therapeutic Education System (TES) for 12 weeks
Number of subjects: 206

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 206
Study: 33339609

Group type: EXPERIMENTAL
Intervention: Alfacalcidol 2 μg/d started 48 hours before surgery and continued throughout the hospital stay
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (no alfacalcidol treatment)
Number of subjects: 86
Study: 32580676

Group type: EXPERIMENTAL
Intervention: Serious Illness Conversation Guide
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Documentation in EHR template
Number of subjects: 25

Group type: COMPARATOR
Intervention: Documentation in progress notes
Number of subjects: 25

Group type: COMPARATOR
Intervention: No documentation
Number of subjects: 25
Study: 33010803

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided ilioinguinal-iliohypogastric block (US-ILIHB) with 0.2% ropivacaine after anesthesia induction
Number of subjects: 103

Group type: COMPARATOR
Intervention: Perifocal wound infiltration (PWI) with 0.2% ropivacaine performed by a surgeon before wound closure
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided ilioinguinal-iliohypogastric block (US-ILIHB)
Number of subjects: 103
Study: 35249118

Group type: EXPERIMENTAL
Intervention: Bacillus coagulans Unique IS-2 supplementation with whey protein
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo group (lactose with whey protein)
Number of subjects: 100
Study: 32223112

Group type: EXPERIMENTAL
Intervention: Apixaban (10 mg twice daily for the first 7 days, followed by 5 mg twice daily)
Number of subjects: 1155

Group type: COMPARATOR
Intervention: Dalteparin (200 IU per kilogram once daily for the first month, followed by 150 IU per kilogram once daily)
Number of subjects: 1155
Study: 36347151

Group type: EXPERIMENTAL
Intervention: Online Mindfulness-Based Intervention (MBI)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 65
Study: 33010590

Group type: EXPERIMENTAL
Intervention: Mailand shoe
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: OrthoWedge shoe
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Podalux shoe
Number of subjects: 20

Group type: COMPARATOR
Intervention: Reference shoe
Number of subjects: 20
Study: 35092723

Group type: EXPERIMENTAL
Intervention: Shared decision-making (SDM) pathway incorporating a digital tool
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1200
Study: 33098633

Group type: EXPERIMENTAL
Intervention: Antenatal corticosteroids (ACS), exposure rate 1.8%, typically >2 weeks before delivery.
Number of subjects: 13976

Group type: EXPERIMENTAL
Intervention: Antenatal corticosteroids (ACS)
Number of subjects: 13976

Group type: COMPARATOR
Intervention: Control group (no ACS exposure)
Number of subjects: 13976
Study: 35034195

Group type: COMPARATOR
Intervention: COPD patients during sleep
Number of subjects: 21
Study: 33727868

Group type: EXPERIMENTAL
Intervention: Yam Daabo six-component intervention
Number of subjects: 1120

Group type: COMPARATOR
Intervention: Standard antenatal and postnatal care (Control)
Number of subjects: 1120
Study: 35852611

Group type: EXPERIMENTAL
Intervention: High-power (45 W)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Moderate-power (35 W)
Number of subjects: 130
Study: 34402789

Group type: EXPERIMENTAL
Intervention: Chemi Enoxaparin (80 mg/0.8 mL)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Clexane (80 mg/0.8 mL)
Number of subjects: 47
Study: 32815902

Group type: EXPERIMENTAL
Intervention: HIV assisted partner services (aPS)
Number of subjects: 550
Study: 36028897

Group type: COMPARATOR
Intervention: Ivermectin
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 33404865

Group type: EXPERIMENTAL
Intervention: Probiotic Milk Formula (PMF)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Skimmed milk drink formula (placebo)
Number of subjects: 40
Study: 33927023

Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard therapy (ST)
Number of subjects: 36
Study: 35680539

Group type: EXPERIMENTAL
Intervention: Behavioral Activation (BA) delivered by trained staff over 8–12 weeks using a structured workbook
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Behavioral Activation (BA) delivered by trained staff
Number of subjects: 188
Study: 33378217

Group type: EXPERIMENTAL
Intervention: Sexual arousal up-regulation
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Disgust down-regulation
Number of subjects: 255

Group type: COMPARATOR
Intervention: Passive control condition
Number of subjects: 255
Study: 33784930

Group type: EXPERIMENTAL
Intervention: Lasmiditan (LTN)
Number of subjects: 14100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14100
Study: 35869734

Group type: EXPERIMENTAL
Intervention: Clostridium butyricum capsules combined with rosuvastatin
Number of subjects: 96
Study: 34559581

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 68

Group type: COMPARATOR
Intervention: Endurance training
Number of subjects: 68
Study: 36207156

Group type: EXPERIMENTAL
Intervention: Aqua Maris Extra Strong irrigation therapy in addition to standard therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard therapy alone
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Aqua Maris Extra Strong irrigation therapy
Number of subjects: 100
Study: 33761717

Group type: EXPERIMENTAL
Intervention: Combined music therapy + Tai Chi
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Music therapy alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tai Chi alone
Number of subjects: 0
Study: 32383801

Group type: EXPERIMENTAL
Intervention: Pharmacist intervention (medication reconciliation at discharge with a link to the community pharmacist)
Number of subjects: 1092

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 1092
Study: 36087064

Group type: EXPERIMENTAL
Intervention: Online compassionate imagery intervention for 2 weeks
Number of subjects: 128
Study: 34772399

Group type: EXPERIMENTAL
Intervention: Topical application of erythropoietin (EPO) 4000 IU/ml for 2 minutes before graft placement
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Topical application of erythropoietin (EPO) 4000 IU/ml
Number of subjects: 17

Group type: COMPARATOR
Intervention: Distilled water (control) for 2 minutes before graft placement
Number of subjects: 17
Study: 35762363

Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Smart Dentin Replacement (SDR)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Ceramic inlays
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (intact teeth)
Number of subjects: 32
Study: 34600629

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (subsymptom threshold), at least 20 min daily for up to 4 weeks
Number of subjects: 118

Group type: COMPARATOR
Intervention: Stretching exercise (placebo-like), at least 20 min daily for up to 4 weeks
Number of subjects: 118
Study: 34020972

Group type: EXPERIMENTAL
Intervention: Acupuncture therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pharmacological interventions
Number of subjects: 0
Study: 34034229

Group type: EXPERIMENTAL
Intervention: Neural gliding mobilization (40 repetitions)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Neural gliding mobilization (80 repetitions)
Number of subjects: 52